Sesamin administration reduced levels of tumor necrosis factor-α (TNF-α) and intercellular adhesion molecule-1 (ICAM-1) and suppressed inducible nitric oxide synthase (iNOS) expression in a mouse model of diabetic retinopathy [54]. The gene discussed is ICAM1; the disease is diabetic retinopathy.